Stay updated on Pembrolizumab for Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 as the page's revision label. This indicates a small, behind-the-scenes update to the site version without visible changes to content or functionality.SummaryDifference0.1%

- Check23 days agoChange DetectedAugust 2026 dates were added to the Study Record Dates and older July dates were removed, reflecting an update to the revision history for NCT03603223.SummaryDifference0.2%

- Check37 days agoChange DetectedFooter revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update. No changes to study content or user actions.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record's update dates were modified. Three new timestamps were added (2026-07-07, 2026-07-09, 2028-08-01) and three older timestamps were removed (2025-07-28, 2025-07-30, 2026-08-01).SummaryDifference0.3%

- Check73 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.